Check out our most popular compounded medications! Get Started
Acetazolamide 500 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance. These capsules are used to treat conditions such as Glaucoma, Epilepsy, Altitude Sickness, Idiopathic Intracranial Hypertension, and Meniere's Disease.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Acetazolamide 500 mg Slow Release Capsules is a specialized medication designed to treat a range of conditions including glaucoma, epilepsy, altitude sickness, idiopathic intracranial hypertension, and Meniere's disease. This unique formulation is crafted with Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, acetazolamide, over an extended period of time. This slow-release mechanism offers consistent therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile.
In the treatment of glaucoma, acetazolamide functions by reducing intraocular pressure through the decreased production of aqueous humor. When used for epilepsy, it aids in reducing the frequency and severity of seizures. For altitude sickness, it alleviates symptoms associated with high altitude, such as headache, dizziness, and fatigue. In cases of idiopathic intracranial hypertension, it works by reducing the pressure within the skull. Lastly, for patients with Meniere's disease, it helps to alleviate symptoms such as vertigo, tinnitus, and hearing loss.
Its unique formulation ensures a steady and controlled release of the active ingredient, providing consistent therapeutic effects and improved patient compliance. If you have any questions about this formulation or how it can help manage your condition, please do not hesitate to contact us at Bayview Pharmacy.
Acetazolamide 500 mg Slow Release Capsules are a compounded formulation designed to treat a variety of conditions including Glaucoma, Epilepsy, Altitude Sickness, Idiopathic Intracranial Hypertension, and Meniere's Disease. This medication functions as an anticonvulsant and a carbonic anhydrase inhibitor. It operates by reducing the production of aqueous humor in the eye, decreasing the fluid in the brain, and lessening the fluid in the inner ear.
The slow-release feature of these capsules, facilitated by the Methocel E4M polymer, allows for the gradual release of the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Acetazolamide 500 mg Slow Release Capsules can be utilized to alleviate eye pressure, decrease the frequency of seizures, and mitigate the symptoms of altitude sickness. Additionally, it can be employed to reduce brain pressure and alleviate the symptoms of Meniere's Disease. The dosage and administration of this medication should be as directed by your healthcare provider.
Common side effects of Acetazolamide 500 mg Slow Release Capsules may encompass nausea, vomiting, loss of appetite, headache, dizziness, and fatigue. If any of these side effects are experienced, it is recommended to contact your healthcare provider. For any queries or concerns regarding Acetazolamide 500 mg Slow Release Capsules, please consult with your healthcare provider.
Acetazolamide 500 mg Slow Release Capsules are a specialized formulation designed to treat a range of conditions such as glaucoma, epilepsy, altitude sickness, idiopathic intracranial hypertension, and Meniere's disease. The active ingredient, Acetazolamide, functions by inhibiting the enzyme carbonic anhydrase, which plays a crucial role in reducing the production of fluid in the eye, brain, and inner ear. This reduction in fluid production helps alleviate pressure in these areas, thereby mitigating the symptoms associated with the aforementioned conditions.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only enhances the efficacy of the medication but also reduces the dosing frequency, thereby improving patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Acetazolamide is typically administered once or twice daily, depending on the specific condition being treated. It is crucial to adhere to the prescribed dosage, as deviations can lead to serious side effects. Common side effects associated with Acetazolamide include nausea, vomiting, loss of appetite, and dizziness. If any of these side effects are experienced, it is recommended to contact your healthcare provider immediately.
If you have any questions or concerns about this medication, please consult with your healthcare provider.
Acetazolamide 500 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time, offering sustained therapeutic effects.
The slow release formulation provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
Due to the slow release formulation, the frequency of dosing is reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
Acetazolamide is a medication used to treat certain types of glaucoma, epilepsy, and to reduce fluid retention in the body. The slow release formulation ensures these therapeutic effects are sustained over a longer period of time.
Yes, the slow release formulation can improve patient compliance. This is because the reduced dosing frequency makes it easier for patients to adhere to their medication schedule.
Acetazolamide 500 mg Slow Release Capsules should only be taken under the supervision of a healthcare provider. It is not suitable for everyone and may have contraindications or cause side effects in some individuals.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up. Always consult your healthcare provider to ensure the information applies to your personal circumstances.
No, the capsules should not be crushed or chewed. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
